S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Addex Therapeutics (ADDXF) News Today

$0.99
0.00 (0.00%)
(As of 02/3/2023)
SourceHeadline
markets.businessinsider.com logoAddex Therapeutics earnings: here's what to expect
markets.businessinsider.com - March 24 at 11:33 AM
investing.com logoAddex Therapeutics Ltd (ADXN)
investing.com - March 22 at 9:03 AM
morningstar.com logoADRs Close Higher; Addex Therapeutics Climbs 21%
morningstar.com - January 25 at 8:04 PM
markets.businessinsider.com logoAddex Therapeutics is about to announce its earnings — here's what to expect
markets.businessinsider.com - November 28 at 10:36 AM
benzinga.com logoAddex Announces Plan to Implement ADS Ratio Change
benzinga.com - October 6 at 5:14 PM
markets.businessinsider.com logoAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
markets.businessinsider.com - September 20 at 3:27 AM
tmcnet.com logoAddex's Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain
tmcnet.com - September 4 at 7:23 AM
benzinga.com logoAddex mGlu2PAM Demonstrates Potential in Substance Use Disorder
benzinga.com - July 24 at 8:21 AM
benzinga.com logoAddex Therapeutics Q1 EPS $(0.04) Up From $(0.97) YoY, Sales $542.43K Up From $264.20K YoY
benzinga.com - May 12 at 8:18 PM
benzinga.com logoAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Study
benzinga.com - May 10 at 3:22 AM
finanznachrichten.de logoAddex Therapeutics: Addex Completes $5.0 Million Equity Financing
finanznachrichten.de - April 5 at 8:46 AM
benzinga.com logoAddex Completes $5.0 Million Equity Financing
benzinga.com - April 5 at 8:46 AM
tmcnet.com logoAddex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson's Disease
tmcnet.com - April 4 at 2:28 AM
markets.businessinsider.com logoAddex Therapeutics FY22 Loss Widens, Income Down
markets.businessinsider.com - March 30 at 2:25 AM
benzinga.com logoAddex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why
benzinga.com - June 17 at 7:52 AM
Get Addex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADDXF and its competitors with MarketBeat's FREE daily newsletter.

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

ADDXF Media Mentions By Week

ADDXF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADDXF
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

ADDXF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADDXF Articles
This Week

0

0

ADDXF Articles
Average Week

Get Addex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADDXF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:ADDXF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners